Cargando…

Whole Genome Sequence Analysis of a Large Isoniazid-Resistant Tuberculosis Outbreak in London: A Retrospective Observational Study

BACKGROUND: A large isoniazid-resistant tuberculosis outbreak centred on London, United Kingdom, has been ongoing since 1995. The aim of this study was to investigate the power and value of whole genome sequencing (WGS) to resolve the transmission network compared to current molecular strain typing...

Descripción completa

Detalles Bibliográficos
Autores principales:	Casali, Nicola, Broda, Agnieszka, Harris, Simon R., Parkhill, Julian, Brown, Timothy, Drobniewski, Francis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5049847/ https://www.ncbi.nlm.nih.gov/pubmed/27701423 http://dx.doi.org/10.1371/journal.pmed.1002137

Ejemplares similares

Genetic variation in Mycobacterium tuberculosis isolates from a London outbreak associated with isoniazid resistance
por: Satta, Giovanni, et al.
Publicado: (2016)

Evolution and transmission of drug resistant tuberculosis in a Russian population
por: Casali, Nicola, et al.
Publicado: (2014)

Discriminatory Ability of Hypervariable Variable Number Tandem Repeat Loci in Population-based Analysis of Mycobacterium tuberculosis Strains, London, UK
por: Velji, Preya, et al.
Publicado: (2009)

Experimental platform utilising melting curve technology for detection of mutations in Mycobacterium tuberculosis isolates
por: Broda, Agnieszka, et al.
Publicado: (2018)

Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: a retrospective observational study
por: Walker, Timothy M, et al.
Publicado: (2013)

MIRU-VNTR Genotyping of Mycobacterium tuberculosis Strains Using QIAxcel Technology: A Multicentre Evaluation Study
por: Nikolayevskyy, Vladyslav, et al.
Publicado: (2016)

Rifampicin Resistance in Tuberculosis Outbreak, London, England
por: Jenkins, Claire, et al.
Publicado: (2005)

Performance of lipid fingerprint-based MALDI-ToF for the diagnosis of mycobacterial infections
por: Gonzalo, Ximena, et al.
Publicado: (2021)

Twenty years and counting: epidemiology of an outbreak of isoniazid-resistant tuberculosis in England and Wales, 1995 to 2014
por: Smith, Catherine M, et al.
Publicado: (2017)

Rapid diagnostics of tuberculosis and drug resistance in the industrialized world: clinical and public health benefits and barriers to implementation
por: Drobniewski, Francis, et al.
Publicado: (2013)

Associations between Mycobacterium tuberculosis Strains and Phenotypes
por: Brown, Timothy, et al.
Publicado: (2010)

COVID-19 Vaccine Hesitancy in Diverse Groups in the UK—Is the Driver Economic or Cultural in Student Populations
por: Drobniewski, Francis, et al.
Publicado: (2022)

Identification and Characterization of Genetic Determinants of Isoniazid and Rifampicin Resistance in Mycobacterium tuberculosis in Southern India
por: Munir, Asma, et al.
Publicado: (2019)

An Improved Method for Rapid Detection of Mycobacterium abscessus Complex Based on Species-Specific Lipid Fingerprint by Routine MALDI-TOF
por: Jia Khor, Min, et al.
Publicado: (2021)

Impact of Isoniazid Resistance-Conferring Mutations on the Clinical Presentation of Isoniazid Monoresistant Tuberculosis
por: Dantes, Raymund, et al.
Publicado: (2012)

Genomic Stability over 9 Years of an Isoniazid Resistant Mycobacterium tuberculosis Outbreak Strain in Sweden
por: Sandegren, Linus, et al.
Publicado: (2011)

Assessment of Mycobacterium tuberculosis transmission in Oxfordshire, UK, 2007–12, with whole pathogen genome sequences: an observational study
por: Walker, Timothy M, et al.
Publicado: (2014)

Mycobacterium tuberculosis and Rifampin Resistance, United Kingdom
por: Sam, I-Ching, et al.
Publicado: (2006)

Treatment of isoniazid-resistant pulmonary tuberculosis
por: Kim, Yee Hyung, et al.
Publicado: (2008)

Treatment of Isoniazid-Resistant Pulmonary Tuberculosis
por: Jhun, Byung Woo, et al.
Publicado: (2020)

Drug Resistant Tuberculosis in Adults and Its Treatment
por: Drobniewski, Francis
Publicado: (1998)

Fluoroquinolones and isoniazid-resistant tuberculosis: implications for the 2018 WHO guidance
por: Stagg, Helen R., et al.
Publicado: (2019)

Minimum inhibitory concentrations of rifampin and isoniazid among multidrug and isoniazid resistant Mycobacterium tuberculosis in Ethiopia
por: Getahun, Muluwork, et al.
Publicado: (2022)

Transmission analysis of a large tuberculosis outbreak in London: a mathematical modelling study using genomic data
por: Xu, Yuanwei, et al.
Publicado: (2020)

Isoniazid-Resistant Tuberculosis, Taiwan, 2000–2010
por: Lai, Chih-Cheng, et al.
Publicado: (2011)

Isoniazid Preventive Therapy and Risk for Resistant Tuberculosis
por: Balcells, Maria Elvira, et al.
Publicado: (2006)

Isoniazid for preventing tuberculosis in HIV‐infected children
por: Zunza, Moleen, et al.
Publicado: (2017)

Isoniazid-induced liver disorder in the treatment of tuberculosis
por: Sivannan, Srinivasan, et al.
Publicado: (2018)

Dose of Isoniazid in Renal Disease for Treatment of Tuberculosis
por: Sarma, G. R. K.
Publicado: (2022)

Differentiation of Tuberculosis Strains in a Population with Mainly Beijing-family Strains
por: Nikolayevskyy, Vladyslav, et al.
Publicado: (2006)

Novel Isoniazid-Carborane Hybrids Active In Vitro against Mycobacterium tuberculosis
por: Różycka, Daria, et al.
Publicado: (2020)

Are the Newer Carbapenems of Any Value against Tuberculosis
por: Gonzalo, Ximena, et al.
Publicado: (2022)

Silent Nucleotide Polymorphisms and a Phylogeny for Mycobacterium tuberculosis
por: Baker, Lucy, et al.
Publicado: (2004)

Safety & Benefits of Directly Observed Therapy with Rifapentine and Isoniazid for Latent Tuberculosis Infection – Less is More?
por: Ha, Lawrence, et al.
Publicado: (2017)

Evaluating the clinical impact of routine whole genome sequencing in tuberculosis treatment decisions and the issue of isoniazid mono-resistance
por: Park, Mirae, et al.
Publicado: (2022)

Optimization of SABRE for polarization of the tuberculosis drugs pyrazinamide and isoniazid
por: Zeng, Haifeng, et al.
Publicado: (2013)

Discovery of Novel Enhancers of Isoniazid Toxicity in Mycobacterium tuberculosis
por: Lentz, Fabian, et al.
Publicado: (2018)

Intrapatient variability in plasma rifampicin & isoniazid in tuberculosis patients
por: Kumar, A. K. Hemanth, et al.
Publicado: (2018)

Emergence and selection of isoniazid and rifampin resistance in tuberculosis granulomas
por: Pienaar, Elsje, et al.
Publicado: (2018)

Electrospun Orodispersible Films of Isoniazid for Pediatric Tuberculosis Treatment
por: Chachlioutaki, Konstantina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_q7u5b3ns3oin94mjodu8uuudob